Homehealthcare investment

healthcare investment

Gilead (GILD), RCUS Announce Positive Data From NSCLC Study

Gilead (GILD), RCUS Announce Positive Data From NSCLC Study

November 29, 2022

Envisagenics Announces Research Collaboration with Bristol Myers Squibb

Envisagenics Announces Research Collaboration with Bristol Myers Squibb

November 29, 2022

AMGEN TO WEBCAST INVESTOR CALL AT WCIRDC 2022

AMGEN TO WEBCAST INVESTOR CALL AT WCIRDC 2022

November 28, 2022

Best Dividend Stocks To Buy Now? 2 To Watch Before December 2022

Best Dividend Stocks To Buy Now? 2 To Watch Before December 2022

November 28, 2022

CONTINUED INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Biogen Inc.’s Directors and Officers for Breach of Fiduciary Duties – BIIB

CONTINUED INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Biogen Inc.’s Directors and Officers for Breach of Fiduciary Duties – BIIB

November 28, 2022

Spectrum’s (SPPI) NDA for NSCLC Candidate Gets CRL From FDA

Spectrum’s (SPPI) NDA for NSCLC Candidate Gets CRL From FDA

November 28, 2022

Here’s What’s Driving AbbVie’s (ABBV) Outperformance This Year

Here’s What’s Driving AbbVie’s (ABBV) Outperformance This Year

November 28, 2022

Beat the Market the Zacks Way: Tenaris, Lululemon, AutoZone in Focus

Beat the Market the Zacks Way: Tenaris, Lululemon, AutoZone in Focus

November 28, 2022

C4X Discovery Holdings plc: C4XD signs exclusive global licence worth up to $402 million¹ with AstraZeneca for the development and commercialisation of NRF2 Activator programme

C4X Discovery Holdings plc: C4XD signs exclusive global licence worth up to $402 million¹ with AstraZeneca for the development and commercialisation of NRF2 Activator programme

November 28, 2022

Bristol-Myers (BMY) to Post Q2 Earnings: What is in the Cards?

Bristol-Myers (BMY) to Post Q2 Earnings: What is in the Cards?

July 25, 2022

« 1 … 18 19 20 21 22 … 449 »